Table IV. Impact of active cancer on patient reported measures.
Preoperative survey measures | |||
---|---|---|---|
Active Cancer (N = 17) | Risk Reduction (N = 22) | p-value | |
Breast Health | 58 (53, 79) | 70 (53, 70) | 0.8866 |
Psychosocial Wellness | 79 (58, 86) | 68.5 (63, 82) | 0.6594 |
Sexual Well-Beinga | 57 (54, 63) | 57 (45, 63) | 0.6505 |
Physical impact (chest) | 74 (68, 85) | 91 (74, 100) | 0.0875 |
Postoperative survey measures | |||
Active Cancer (N = 17) | Risk Reduction (N = 22) | p-value | |
Breast Health | 71 (61, 78) | 76.5 (69, 85) | 0.0990 |
Psychosocial Wellness | 73 (65, 92) | 92 (82, 100) | 0.0194* |
Sexual Well-Beingb | 57 (47, 67) | 60 (50.5, 80) | 0.2595 |
Physical impact (chest)c | 72.5 (58.5, 79) | 79 (77, 100) | 0.0098* |
Overall satisfaction with outcome | 75 (67, 75) | 75 (75, 100) | 0.0326* |
Difference between preoperative and postoperative survey measures | |||
Active Cancer (N = 17) | Risk Reduction (N = 22) | p-value | |
Breast Health | 6 (-7, 15) | 8.5 (-4, 28) | 0.4744 |
Psychosocial Wellness | 1 (-16, 24) | 17 (10, 33) | 0.0427* |
Sexual Well-Beingd | 0 (-8, 15) | 20 (-5, 70) | 0.0767 |
Physical impact (chest)c | -10.5 (-14, 6) | 0 (-14, 9) | 0.6171 |
N=21 patients in the Risk Reduction group
N=20 patients in the Risk Reduction group
N=16 patients in the Active Cancer group
N=19 patients in the Risk Reduction group
p <.05 by Wilcoxon Rank-Sum Test